Medicinal chemistry insights in the discovery of novel LSD1 inhibitors.
LSD1 is an epigenetic modulator associated with transcriptional regulation of genes involved in a broad spectrum of key cellular processes, and its activity is often altered under pathological conditions. LSD1 inhibitors are considered to be candidates for therapy of cancer, viral diseases and neurodegeneration. Many LSD1 inhibitors with various scaffolds have been disclosed, and a few potent molecules are in different stages of clinical development. In this review, we summarize recent biological findings on the roles of LSD1 and the current understanding of the clinical significance of LSD1, and focus on the medicinal chemistry strategies used in the design and development of LSD1 inhibitors as drug-like epigenetic modulators since 2012, including a brief consideration of structure-activity relationships.
['Wang|Xueshun|X|', 'Huang|Boshi|B|', 'Suzuki|Takayoshi|T|', 'Liu|Xinyong|X|', 'Zhan|Peng|P|']
D000818:Animals D002626:Chemistry, Pharmaceutical D055808:Drug Discovery D004791:Enzyme Inhibitors D044127:Epigenesis, Genetic D056466:Histone Demethylases D006801:Humans D013329:Structure-Activity Relationship
medicinal chemistry LSD1 drug design epigenomics histone modification